Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REINFORCE
NCT07325500Phase 2Recruiting
- Sponsor
- UTHealth Houston
- Start
- Feb 2026
- Primary completion
- May 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide, sponsored by UTHealth Houston. Started Feb 2026; status: recruiting.
02
Drugs
Beyond the preview
Go deeper on NCT07325500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07325500.